EXACT Sciences Corporation (EXAS) : $5.15 million worth of transactions were on upticks in EXACT Sciences Corporation (EXAS), compared to $4.48 million on downticks. The ratio between the two was 1.15, whereas, the net money flow stood at a healthy $0.67 million on Tuesdays session.The block trades show a bullish bias with only $0.44 million worth of transactions done on downticks. The consistent buying on upticks in the stock accounted for $1.87million worth of trades. The up-down ratio between the uptick and downtick was 4.27, confirming that the stronger hands have been buying the stock on every weakness. The total money flow into the stock stood at $1.43 million. The bulls and the bears were in an equilibrium as the stock closed with a loss of -1.59%. The stock was trading at $12.4, with a drop of $0.2 over the previous days close. The stock recorded -0.24% for the week.
The company Insiders own 5.5% of EXACT Sciences Corporation shares according to the proxy statements. Institutional Investors own 82.09% of EXACT Sciences Corporation shares. During last six month period, the net percent change held by insiders has seen a change of 6.93%. In an insider trading activity, Coward D Scott, officer (SVP and General Counsel) of Exact Sciences Corp, unloaded 1,644 shares at an average price of $12.28 on July 1, 2016. The total amount of the transaction was worth $20,188, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Shares of Exact Sciences Corporation rose by 13.41% in the last five trading days and 92.42% for the last 4 weeks. Exact Sciences Corporation is up 88.9% in the last 3-month period. Year-to-Date the stock performance stands at 45.72%.
EXACT Sciences Corporation (NASDAQ:EXAS): stock turned positive on Tuesday. Though the stock opened at $12.66, the bulls momentum made the stock top out at $13.68 level for the day. The stock recorded a low of $12.36 and closed the trading day at $13.45, in the green by 6.75%. The total traded volume for the day was 7,854,014. The stock had closed at $12.6 in the previous days trading.
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The Company has developed a non?invasive screening test called Cologuard for colorectal cancer. Its Cologuard test is a non?invasive stool?based deoxyribonucleic acid (DNA) (sDNA) screening test designed to detect DNA markers. In addition to DNA markers, its test includes a protein marker to detect blood in the stool, utilizing an antibody?based fecal immunochemical test (FIT). The Companys Cologuard test is designed to detect pre?cancerous lesions or polyps, and each of the four stages of colorectal cancer. By detecting pre?cancers and cancers early with its test, affected patients can be referred to colonoscopy, during which the polyps or lesions can be removed. The companys test also detects blood in stool, utilizing an antibody based FIT test.